http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1406345-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bee8b2c674d7ec672688001f27aa95fe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-71
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-10
filingDate 1973-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1406345-A
titleOfInvention Pharmaceutical preparations comprising substituted resorcinols
abstract 1406345 Compositions containing resorcinols CHEM. PHARMAZ FABRIK DR. HERMANN THIEMANN GmbH 11 Oct 1973 [13 Oct 1972] 47496/73 Heading A5B [Also in Division C2] A pharmaceutical composition comprises a resorcinol of the general formula wherein X represents an oxygen atom or an -NH group, R<SP>1</SP> represents a hydrogen atom or a methyl group, R<SP>2</SP> represents a hydrogen atom or a methyl, alkoxycarbonyl or group, R<SP>3</SP> represents the group wherein R<SP>1</SP> and R<SP>2</SP> have the above-mentioned meaning, R<SP>4</SP> represents a hydrogen atom, R<SP>5</SP> represents a hydrogen atom or the group R<SP>3</SP>, R<SP>6</SP> represents a hydrogen atom or a hydroxyl group or R<SP>3</SP> and R<SP>4</SP> together denote the radical wherein R<SP>1</SP> and R<SP>2</SP> have the above meaning, or a physiologically tolerable salt thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993556-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010121963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7728016-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005000300-A1
priorityDate 1972-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 37.